119 related articles for article (PubMed ID: 16108245)
41. Malignancy-related hypercalcemia developing on a bisphosphonate but responding to calcitonin.
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
Clin Lung Cancer; 2007 Jul; 8(7):434-5. PubMed ID: 17681097
[TBL] [Abstract][Full Text] [Related]
42. Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies.
Cosman F; Borges JL; Curiel MD
Clin Ther; 2007 Jun; 29(6):1116-27. PubMed ID: 17692726
[TBL] [Abstract][Full Text] [Related]
43. Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.
Miller PD
Clin Ther; 2005 Apr; 27(4):361-76. PubMed ID: 15922811
[TBL] [Abstract][Full Text] [Related]
44. Atypical fractures on long term bisphosphonates therapy.
Hussein W; Cunningham C; Logan H; Fallon C; Murphy S
Ir Med J; 2011; 104(10):308, 310. PubMed ID: 22256444
[TBL] [Abstract][Full Text] [Related]
45. The clinical tolerability profile of alendronate.
Watts N; Freedholm D; Daifotis A
Int J Clin Pract Suppl; 1999 Apr; 101():51-61. PubMed ID: 12669741
[TBL] [Abstract][Full Text] [Related]
46. [Diphosphonate therapy and osteonecrosis of the jaw].
Løkken P; Skoglund LA; Skjelbred P
Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
[No Abstract] [Full Text] [Related]
47. Treatment of osteoporosis with bisphosphonates.
Watts NB
Rheum Dis Clin North Am; 1994 Aug; 20(3):717-34. PubMed ID: 7984786
[TBL] [Abstract][Full Text] [Related]
48. [Treating with what? Therapy for how long?].
MMW Fortschr Med; 2005 Dec; 147(51-52):62-3. PubMed ID: 16402713
[No Abstract] [Full Text] [Related]
49. Alendronate-induced synovitis.
Gwynne Jones DP; Savage RL; Highton J
J Rheumatol; 2008 Mar; 35(3):537-8. PubMed ID: 18203307
[TBL] [Abstract][Full Text] [Related]
50. Bisphosphonate-associated orbital inflammation--a case report and review.
Peterson JD; Bedrossian EH
Orbit; 2012 Apr; 31(2):119-23. PubMed ID: 22489855
[TBL] [Abstract][Full Text] [Related]
51. Bisphosphonates: uveitis and scleritis.
Prescrire Int; 2013 May; 22(138):128. PubMed ID: 23819179
[No Abstract] [Full Text] [Related]
52. Aminobisphosphonate-associated orbital and ocular inflammatory disease.
Keren S; Leibovitch I; Ben Cnaan R; Neudorfer M; Fogel O; Greenman Y; Shulman S; Zur D; Habot-Wilner Z
Acta Ophthalmol; 2019 Aug; 97(5):e792-e799. PubMed ID: 30816018
[TBL] [Abstract][Full Text] [Related]
53. [Persistent polyarticular synovitis after treatment with alendronate].
Frederiksen L; Junker P; Brixen KT
Ugeskr Laeger; 2007 Apr; 169(17):1583-4. PubMed ID: 17484832
[TBL] [Abstract][Full Text] [Related]
54. [Alendronate-induced hepatocellular lesion].
de La Serna Higuera C; Pérez Villoria A; Rodríguez Gómez S; Martínez Moreno J; Betancourt González A; Martín Arribas M
Gastroenterol Hepatol; 2001 May; 24(5):244-6. PubMed ID: 11412594
[TBL] [Abstract][Full Text] [Related]
55. Orbital myositis induced by alendronate: A case report.
Lefeuvre L; Caruso A; Biver E; Fayolle D
Eur J Neurol; 2023 Jun; 30(6):1828-1830. PubMed ID: 36880870
[TBL] [Abstract][Full Text] [Related]
56. Esophagitis associated with the use of alendronate.
de Groen PC; Lubbe DF; Hirsch LJ; Daifotis A; Stephenson W; Freedholm D; Pryor-Tillotson S; Seleznick MJ; Pinkas H; Wang KK
N Engl J Med; 1996 Oct; 335(14):1016-21. PubMed ID: 8793925
[TBL] [Abstract][Full Text] [Related]
57. Pamidronate disodium and possible ocular adverse drug reactions.
Macarol V; Fraunfelder FT
Am J Ophthalmol; 1994 Aug; 118(2):220-4. PubMed ID: 8053468
[TBL] [Abstract][Full Text] [Related]
58. Scleritis and Intraorbital Inflammation following Oral and Intravenous Bisphosphonates in a 66-Year-Old Man.
Heck K; Malinina S; Palmowski A
Klin Monbl Augenheilkd; 2024 Apr; 241(4):426-428. PubMed ID: 38653272
[No Abstract] [Full Text] [Related]
59. Esophagitis dissecans superficialis and alendronate: case report.
Cameron RB
Gastrointest Endosc; 1997 Dec; 46(6):562-3. PubMed ID: 9434230
[No Abstract] [Full Text] [Related]
60. Hepatitis after alendronate.
Lieverse RJ
Neth J Med; 1998 Dec; 53(6):271-2. PubMed ID: 9883006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
